Advertisement

Topics

Critical Therapeutics, Inc. Company Profile

19:42 EST 17th November 2017 | BioPortfolio

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to the asthma drug ZYFLO® (zileuton tablets), as well as other formulations of zileuton. ZYFLO is the only 5-lipoxygenase inhibitor approved for marketing by the U.S. Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. The Company’s commercialization efforts for ZYFLO are carried out by its 80-person specialty sales force.

Location

60 Westview Street
Lexington
Massachusetts
02421
United States of America

Contact

Phone: (781) 402-5700.
Email: busdev@crtx.com


News Articles [608 Associated News Articles listed on BioPortfolio]

Opexa Therapeutics, Inc.: Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement

Merger to create a pre-NDA-stage, NASDAQ-listed, pharmaceutical company focused on the development and commercialization of therapies for serious rare diseases with critical unmet medical need Conc...

Critical Limb Ischemia Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1500

DelveInsight's, Critical Limb Ischemia Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Critical Limb Ischemia. The key objective of the report is to e...

Critical Contrast: Aimmune Therapeutics

Aimmune Therapeutics and Novan are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst r...

Windtree Therapeutics (WINT) versus Oncolytics Biotech (NASDAQ:ONCY) Critical Analysis

Windtree Therapeutics and Oncolytics Biotech are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, an...

Global Blood Therapeutics: Addressing A Sickle That Impedes Critical Cycling

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

FDA Grants Fast Track Designation to Pluristem Therapeutics's PLX-PAD For the Treatment Of Critical Limb Ischemia (CLI)

  Life Sciences Jobs   ...

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

PubMed Articles [1456 Associated PubMed Articles listed on BioPortfolio]

The Current State of Peptide Drug Discovery: Back to the Future?

Over the last decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role that peptide therapeutics can...

Immunogenicity assessment during the development of protein therapeutics.

Here we provide a critical review of the state of the art with respect to non-clinical assessments of immunogenicity for therapeutic proteins.

Functional and therapeutic significance of EZH2 in urological cancers.

The enhancer of zeste homolog 2 (EZH2) is a core subunit of the polycomb repressor complex 2 (PRC2), which is overexpressed in numerous cancers and mutated in several others. Notably, EZH2 acts not on...

Cellular therapies in trauma and critical care medicine: Looking towards the future.

Shibani Pati and Todd Rasmussen summarize progress in preclinical research on cellular therapeutics for traumatic injury and its sequelae and discuss prospects for clinical translation.

A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.

Discovery and validation of new antibody tractable targets is critical for the development of new antibody therapeutics to address unmet needs in oncology.

Clinical Trials [1031 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness

This study will identify the changes in different muscles of patients receiving Extracorporeal Membrane Oxygenation (ECMO) during critical illness and admission to Intensive Care Unit (ICU...

Companies [1917 Associated Companies listed on BioPortfolio]

Critical Therapeutics, Inc.

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company...

Proteon Therapeutics Inc.

Proteon Therapeutics Inc. is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kid...

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Proteon Therapeutics, Inc.

Proteon Therapeutics, Inc., is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular di...

Proteon Therapeutics

Proteon Therapeutics, Inc. is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with ki...

More Information about "Critical Therapeutics, Inc." on BioPortfolio

We have published hundreds of Critical Therapeutics, Inc. news stories on BioPortfolio along with dozens of Critical Therapeutics, Inc. Clinical Trials and PubMed Articles about Critical Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Critical Therapeutics, Inc. Companies in our database. You can also find out about relevant Critical Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record